Maxcyte (MXCT) Long-Term Debt Issuances (2021)
Maxcyte's (MXCT) quarterly Long-Term Debt Issuances came in at $4.9 million in Q1 2021.
Maxcyte (MXCT) Long-Term Debt Issuances (2021) Analysis & Trends
Maxcyte (MXCT) has 1 years of Long-Term Debt Issuances data on file, last reported at $4.9 million in Q1 2021.
- On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to $4.9 million in Q1 2021; TTM through Dec 2021 was $4.9 million, a N/A change from a year earlier, with the FY2021 full-year figure at $4.9 million, up 241.83% from the prior year.
- Long-Term Debt Issuances for Q1 2021 stood at $4.9 million.
- Over the last five years, Long-Term Debt Issuances for MXCT reached as high as $4.9 million in Q1 2021 and fell as low as $4.9 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 19.86 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 1.15 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 11.71 Mn |
| 10 | Maxcyte | 110.62 Mn | 110.62 Mn | 8.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 4.92 Mn |
| Mar 31, 2021 | 4.92 Mn |